BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 36033509)

  • 1. Prognostic significance of CNSL at diagnosis of childhood B-cell acute lymphoblastic leukemia: A report from the South China Children's Leukemia Group.
    Xu LH; Geng X; Liao N; Yang LH; Mai HR; Wan WQ; Huang LB; Zheng MC; Tian C; Chen HQ; Chen QW; Long XJ; Zhen ZJ; Liu RY; Li QR; Wu BY; Wang LN; Kong XL; Chen GH; Fang JP; Li Y
    Front Oncol; 2022; 12():943761. PubMed ID: 36033509
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic significance of cerebrospinal fluid flow cytometry in Chinese children with B lineage acute lymphoblastic leukemia.
    Tang X; Mai H; Wang L; Chen S; Chen F; Li T; Liu Y; Zhou G; Liu S; Wang Y; Liu S; Fu X; Wen F
    BMC Pediatr; 2024 Mar; 24(1):204. PubMed ID: 38519960
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical Characteristics and Prognosis of 21 Cases of Acute Lymphoblastic Leukemia with Central Nervous System Leukemia].
    Jin XS; Yang L; Wang BH; Li HH; Yu L; Jing Y
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Dec; 24(6):1675-1682. PubMed ID: 28024476
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic Value and Prognosis Significance of Cerebrospinal Fluid Examination by Flow Cytometry in Pediatric Acute Lymphoblastic Leukemia.
    Xue L; Shang Q; Lu A; Zuo Y; Ding M; Zhang L; Jia Y
    Technol Cancer Res Treat; 2023; 22():15330338231181025. PubMed ID: 37350078
    [No Abstract]   [Full Text] [Related]  

  • 5. The prognostic significance of serum and cerebrospinal fluid MMP-9, CCL2 and sVCAM-1 in leukemia CNS metastasis.
    Si MY; Fan ZC; Li YZ; Chang XL; Xie QD; Jiao XY
    J Neurooncol; 2015 Apr; 122(2):229-44. PubMed ID: 25630624
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of Initial CSF Findings on Outcome Among Patients With National Cancer Institute Standard- and High-Risk B-Cell Acute Lymphoblastic Leukemia: A Report From the Children's Oncology Group.
    Winick N; Devidas M; Chen S; Maloney K; Larsen E; Mattano L; Borowitz MJ; Carroll A; Gastier-Foster JM; Heerema NA; Willman C; Wood B; Loh ML; Raetz E; Hunger SP; Carroll WL
    J Clin Oncol; 2017 Aug; 35(22):2527-2534. PubMed ID: 28535084
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New attempts for central nervous infiltration of pediatric acute lymphoblastic leukemia.
    Zhou F; Wen Y; Jin R; Chen H
    Cancer Metastasis Rev; 2019 Dec; 38(4):657-671. PubMed ID: 31820149
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictive role of cerebrospinal fluid hydrogen sulfide in central nervous system leukemia.
    DU SX; Xiao J; Guan F; Sun LM; Wu WS; Tang H; DU JB; Tang CS; Jin HF
    Chin Med J (Engl); 2011 Nov; 124(21):3450-4. PubMed ID: 22340157
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improvement in CNS protective treatment in non-high-risk childhood acute lymphoblastic leukemia: report from the Japanese Children's Cancer and Leukemia Study Group.
    Tsurusawa M; Katano N; Yamamoto Y; Hirota T; Koizumi S; Watanabe A; Takeda T; Hatae Y; Yatabe M; Mimaya J; Gushiken T; Nishi K; Anami K; Kikuta A; Kanegane H; Asami K; Nishikawa K; Sekine I; Kawano Y; Iwai A; Furuyama T; Ijichi O; Miyake M; Mugishima H; Fujimoto T
    Med Pediatr Oncol; 1999 Apr; 32(4):259-6. PubMed ID: 10102019
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ponatinib therapy in recurrent Philadelphia chromosome-positive central nervous system leukemia with T315I mutation after Allo-HSCT.
    He JB; Zhang X; Guo ZW; Liu MM; Xu N; Huang F; Fan ZP; Xuan L; Deng L; Lin SH; Xu J; Sun J; Liu QF
    Int J Cancer; 2020 Aug; 147(4):1071-1077. PubMed ID: 31785158
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High peripheral blast count in adult acute myelogenous leukemia is a primary risk factor for CNS leukemia.
    Cassileth PA; Sylvester LS; Bennett JM; Begg CB
    J Clin Oncol; 1988 Mar; 6(3):495-8. PubMed ID: 3162514
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A phase 2 study of sorafenib combined with conventional therapies in refractory central nervous system leukemia.
    Chen X; Huang J; Xu N; Fan Z; Nie D; Huang F; Sun Q; Zhang X; Liang X; Shi P; Wang Z; Liu H; Xu J; Dai M; Yu G; Zhang Y; Sun J; Liu Q; Xuan L
    Cancer; 2022 Jun; 128(11):2138-2147. PubMed ID: 35315510
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A practical strategy of monitoring minimal residue disease and intervention for central nervous system relapse of childhood acute lymphoblastic leukemia: a single Chinese center's experience.
    Liang Y; Ca Q; Zhai ZM; Wang NL
    J Pediatr Hematol Oncol; 2013 Jul; 35(5):388-93. PubMed ID: 23787730
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improved outcome for children with acute lymphoblastic leukemia: results of Total Therapy Study XIIIB at St Jude Children's Research Hospital.
    Pui CH; Sandlund JT; Pei D; Campana D; Rivera GK; Ribeiro RC; Rubnitz JE; Razzouk BI; Howard SC; Hudson MM; Cheng C; Kun LE; Raimondi SC; Behm FG; Downing JR; Relling MV; Evans WE;
    Blood; 2004 Nov; 104(9):2690-6. PubMed ID: 15251979
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment strategies in primary vitreoretinal lymphoma: a 17-center European collaborative study.
    Riemens A; Bromberg J; Touitou V; Sobolewska B; Missotten T; Baarsma S; Hoyng C; Cordero-Coma M; Tomkins-Netzer O; Rozalski A; Tugal-Tutkun I; Guex-Crosier Y; Los LI; Bollemeijer JG; Nolan A; Pawade J; Willermain F; Bodaghi B; ten Dam-van Loon N; Dick A; Zierhut M; Lightman S; Mackensen F; Moulin A; Erckens R; Wensing B; le Hoang P; Lokhorst H; Rothova A
    JAMA Ophthalmol; 2015 Feb; 133(2):191-7. PubMed ID: 25412269
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence and risk factors for central nervous system relapse in children and adolescents with acute lymphoblastic leukemia.
    Cancela CS; Murao M; Viana MB; de Oliveira BM
    Rev Bras Hematol Hemoter; 2012; 34(6):436-41. PubMed ID: 23323068
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intrathecal triple therapy decreases central nervous system relapse but fails to improve event-free survival when compared with intrathecal methotrexate: results of the Children's Cancer Group (CCG) 1952 study for standard-risk acute lymphoblastic leukemia, reported by the Children's Oncology Group.
    Matloub Y; Lindemulder S; Gaynon PS; Sather H; La M; Broxson E; Yanofsky R; Hutchinson R; Heerema NA; Nachman J; Blake M; Wells LM; Sorrell AD; Masterson M; Kelleher JF; Stork LC;
    Blood; 2006 Aug; 108(4):1165-73. PubMed ID: 16609069
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low leukocyte counts with blast cells in cerebrospinal fluid of children with newly diagnosed acute lymphoblastic leukemia.
    Mahmoud HH; Rivera GK; Hancock ML; Krance RA; Kun LE; Behm FG; Ribeiro RC; Sandlund JT; Crist WM; Pui CH
    N Engl J Med; 1993 Jul; 329(5):314-9. PubMed ID: 8321259
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CNS-3 status remains an independent adverse prognosis factor in children with acute lymphoblastic leukemia (ALL) treated without cranial irradiation: Results of EORTC Children Leukemia Group study 58951.
    Sirvent N; Suciu S; De Moerloose B; Ferster A; Mazingue F; Plat G; Yakouben K; Uyttebroeck A; Paillard C; Costa V; Simon P; Pluchart C; Poirée M; Minckes O; Millot F; Freycon C; Maes P; Hoyoux C; Cavé H; Rohrlich P; Bertrand Y; Benoit Y;
    Arch Pediatr; 2021 Jul; 28(5):411-416. PubMed ID: 34034929
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Long-term outcome of childhood T-cell acute lymphoblastic leukemia treated with modified national protocol of childhood leukemia in China-acute lymphoblastic leukemia 2008].
    Liao C; Shen DY; Xu XJ; Xu WQ; Zhang JY; Song H; Yang SL; Zhao FY; Shen HP; Tang YM
    Zhonghua Er Ke Za Zhi; 2020 Sep; 58(9):758-763. PubMed ID: 32872717
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.